TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
This Quarter Return
+11.91%
1 Year Return
+39.44%
3 Year Return
+251.65%
5 Year Return
+418.54%
10 Year Return
–
AUM
$528M
AUM Growth
+$528M
(+10%)
Cap. Flow
+$15.1M
Cap. Flow
% of AUM
2.87%
Top 10 Holdings %
Top 10 Hldgs %
24.64%
Holding
106
New
27
Increased
32
Reduced
25
Closed
22
Top Buys
| 1 |
CUB
Cubic Corporation
CUB
|
$12.5M |
| 2 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$9.21M |
| 3 |
Vertex
VERX
|
$7.72M |
| 4 |
MODV
ModivCare
MODV
|
$6.25M |
| 5 |
CACI
CACI
|
$5.91M |
Top Sells
| 1 |
Strategic Education
STRA
|
$8.56M |
| 2 |
Charles River Laboratories
CRL
|
$6.4M |
| 3 |
NATI
National Instruments Corp
NATI
|
$5.66M |
| 4 |
Kadant
KAI
|
$5.35M |
| 5 |
Healthcare Services Group
HCSG
|
$5.09M |
Sector Composition
| 1 | Healthcare | 28.7% |
| 2 | Technology | 26.53% |
| 3 | Industrials | 17.04% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Financials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kinsale Capital Group
KNSL
$10.7B
| $16.7M | 3.17% | 87,815 -8,897 | -9% | -$1.69M |
|
2
Emergent Biosolutions
EBS
$443M
| $13.5M | 2.56% | 130,526 -12,870 | -9% | -$1.33M |
|
|
PRAH
3
DELISTED
PRA Health Sciences, Inc.
PRAH
| $13.4M | 2.54% | 132,293 +50,635 | +62% | +$5.14M |
|
4
Cavco Industries
CVCO
$4.2B
| $13.4M | 2.53% | 74,093 +7,818 | +12% | +$1.41M |
|
5
Natera
NTRA
$23.1B
| $13.3M | 2.52% | 184,254 -28,834 | -14% | -$2.08M |
|
|
CUB
6
DELISTED
Cubic Corporation
CUB
| $12.5M | 2.37% | +214,815 | New | +$12.5M |
|
7
Repligen
RGEN
$6.88B
| $12.2M | 2.3% | 82,367 -128 | -0.2% | -$18.9K |
|
8
Bio-Rad Laboratories Class A
BIO
$8.06B
| $11.9M | 2.25% | 23,013 -1,821 | -7% | -$939K |
|
9
WNS Holdings
WNS
$3.24B
| $11.7M | 2.21% | 182,533 +3,293 | +2% | +$211K |
|
10
Genpact
G
$7.9B
| $11.6M | 2.19% | 297,073 +14,799 | +5% | +$576K |
|
|
11
CACI
CACI
$10.6B
| $10.2M | 1.93% | 47,789 +27,718 | +138% | +$5.91M |
|
|
LHCG
12
DELISTED
LHC Group LLC
LHCG
| $9.97M | 1.89% | 46,914 +847 | +2% | +$180K |
|
13
Quanta Services
PWR
$56.3B
| $9.66M | 1.83% | 182,693 +3,285 | +2% | +$174K |
|
14
TFI International
TFII
$7.87B
| $9.48M | 1.8% | 226,700 +20,325 | +10% | +$850K |
|
15
Kratos Defense & Security Solutions
KTOS
$11.1B
| $9.41M | 1.78% | 487,796 +145,408 | +42% | +$2.8M |
|
16
Nice
NICE
$8.73B
| $9.21M | 1.75% | 40,581 +737 | +2% | +$167K |
|
|
SILK
17
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $9.21M | 1.75% | +137,010 | New | +$9.21M |
|
18
LeMaitre Vascular
LMAT
$2.16B
| $8.92M | 1.69% | 274,157 +94,489 | +53% | +$3.07M |
|
19
SPDR S&P Biotech ETF
XBI
$5.07B
| $8.9M | 1.69% | 79,879 +1,626 | +2% | +$181K |
|
20
WillScot Mobile Mini Holdings
WSC
$4.41B
| $8.9M | 1.69% | 533,298 -160,138 | -23% | -$2.67M |
|
21
ASGN Inc
ASGN
$2.38B
| $8.74M | 1.66% | 137,423 -42,683 | -24% | -$2.71M |
|
22
Pacira BioSciences
PCRX
$1.2B
| $8.38M | 1.59% | 139,335 +62,160 | +81% | +$3.74M |
|
23
Ligand Pharmaceuticals
LGND
$3.15B
| $8.29M | 1.57% | 86,995 -38,106 | -30% | -$3.63M |
|
|
24
Charles River Laboratories
CRL
$8.04B
| $7.91M | 1.5% | 34,910 -28,248 | -45% | -$6.4M |
|
25
Onto Innovation
ONTO
$5.19B
| $7.9M | 1.5% | 265,301 -12,277 | -4% | -$366K |
|